Analisis Rasionalitas Peresepan Antibiotik Pada Pasien Infeksi Saluran Kemih Dengan Metode Gyssens di Rumah Sakit X Samarinda
DOI:
https://doi.org/10.30595/pharmacy.v21i1.17582Keywords:
Antibiotik, Alur Gyssens, Infeksi Saluran Kemih, RasionalitasAbstract
Infeksi saluran kemih disebabkan oleh perkembangbiakan mikroba yang terjadi di sepanjang sistem saluran kemih, termasuk ginjal. Memberikan gambaran profil peresepan pasien infeksi saluran kemih di Rumah Sakit X Kota Samarinda dan menilai rasionalitas peresepan antibiotik untuk pasien infeksi saluran kemih di Rumah Sakit X Kota Samarinda. Desain penelitian ini menggunakan observasional deskriptif analitik dengan desain Cohort retrospektif. Pengambilan sampel menggunakan Teknik purposive sampling. Subyek penelitian ini adalah semua pasien ISK Yang memenuhi kriteria inklusi dan eksklusi penelitian yang dirawat di RS X Kota Samarinda selama periode Januari 2020-Agustus 2022. Pasien ISK di Rumah Sakit X Kota Samarinda tahun Januari 2020 - Agustus 2022 sebanyak 55 pasien (rekam medis).Berdasarkan temuan penelitian ini, antibiotik Ceftriaxone merupakan antibiotik paling banyak digunakan sebanyak 53,37%, diikuti Levofloxacin (10,44%), Terfacef (5,97%), Ciprofloxacin (5,97%), Cefixime (2,98%), Cefoperazone Sulbactam (2,98%), Baguinor (1,49%), Ceftazidime (1,49%), Gentamisin (1,49%), Meropenem (1,49%), Urotractin dan Azithromycin (1,49%). Semua berjumlah 67 regimen ditemukan memiliki ketidakrasionalan dengan rincian adalah kategori IIB sebanyak 68,65% (46 regimen) kategori IIA sebanyak 64,17% (43 regimen), kategori IIIB sebanyak 62,68% (42 regimen), Kategori V sebanyak 4,47% (3 regimen), kategori IIIA sebanyak 1,49% (2 regimen) dan IIC sebanyak 1,49% (2 regimen).
References
Alves da Costa F, van Mil JWF, Alvarez-Risco A. 2019. The Pharmacist Guide to Implementing Pharmaceutical Care. Springer International Publishing.
Bass JW, Freitas BC, Freitas AD, Sister CL, Chan DS, Vincent JM, Person DA, Claybaugh JR, Wittler RR, Weisse ME, Regnery RL, Slater LN. 1998. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatric Infectious Disease Journal, 17(6), 447–452.
Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, Kranz J, Schubert S, Pilatz A, Veeratterapillay R, Wagenlehner F. 2023. EAU Guidelines on Urological Infections Infections.
Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. 2016. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ (Clinical Research Ed.), 352, i939.
Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, Wain J, White NJ, Farrar JJ. 2000. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrobial Agents and Chemotherapy, 44(7), 1855–1859.
Cuiban E, Radulescu D, David C, Turcu FL, Bogeanu C, Feier LF, Onofrei SD, Vacaroiu IA. 2023. WCN23-0468 Urinary tract infections in chronic kidney disease patients - A Romanian center experience. Kidney International Reports, 8(3), S272.
Cunha BA, Schoch PE, Bottone EJ, Rex JH, Cunha CB. 2015. Antibiotic susceptibility profiles and initial therapy of isolates pending susceptibility results. In B. A. Cunha (Ed.), Antibiotic (Fourteenth, pp. 185–202). Jaypee Brothers Medical Publishers.
Dager WE, King JH. 2006. Aminoglycosides in Intermittent Hemodialysis: Pharmacokinetics with Individual Dosing. Annals of Pharmacotherapy, 40(1), 9–14.
Damayanti E, Wahyono D, Nuryastuti T. 2020. Rasionalitas penggunaan antibiotik pada pasien infeksi saluran kemih oleh bakteri penghasil ESBL (Extended Spectrum Beta-Lactamase) di RSUP Dr. Sardjito Yogyakarta. Majalah Farmaseutik, 17(2), 225–232.
Dolecek C, Phi La TT, Rang NN, Phuong LT, Vinh H, Tuan PQ, Cong Du D, Be Bay NT, Long DT, Ha LB, Binh NT, Anh Hong NT, Dung PN, Lanh MN, Be Bay P, Van Ho VA, Van Minh Hoang N, Nga TTT, Chau TT, Farrar J. 2008.. A multi-center randomised controlled trial of Gatifloxacin versus Azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS ONE, 3(5), e2188.
Durham SH. 2022. Urinary tract infections and prostatitis. In M. A. Chisholm-Burns, T. L. Schwinghammer, P. M. Malone, J. M. Kolesar, K. C. Lee, & P. Brandon Bookstaver (Eds.), Pharmacotherapy Principles & Practice (Sixth, pp. 1289–1298). McGraw Hill.
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Levy M. 2021. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine, 47(11), 1181–1247.
Fagan M, Lindbæk M, Grude N, Reiso H, Romøren M, Skaare D, Berild D. 2015. Antibiotic resistance patterns of bacteria causing urinary tract infections in the elderly living in nursing homes versus the elderly living at home: An observational study. BMC Geriatrics, 15, 98.
Fernandez JM, Coyle EA. 2023. Urinary tract infections and prostatitis. In J. T. DiPiro, G. C. Yee, S. T. Haines, T. D. Nolin, V. Ellingrod, & L. Michael Posey (Eds.), Dipiro’s Pharmacotherapy A Pathophysiologic Approach (12th ed., pp. 3732–3767). McGraw Hill.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. 2015. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology, 13(5), 269–284.
Geerlings SE, Van Nieuwkoop C, Van Haarst E, Van Buren M, Knottnerus B, Stobberingh EE, De Groot C, Prins J. 2013. SWAB Guidelines for Antimicrobial Therapy of Complicated Urinary Tract Infections in Adults. SWAB Guidelines.
Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, Khakhria R. 1999. Azithromycin versus Ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrobial Agents and Chemotherapy, 43(6), 1441–1444.
Gupta K. 2023a. Acute simple cystitis in adult and adolescent females. UpToDate.
Gupta K. 2023b. Acute simple cystitis in adult and adolescent males. UpToDate.
Gupta K. 2023c. Acute complicated urinary tract infection (including pyelonephritis) in adults and adolescents. UpToDate.
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz, R, Schaeffer AJ, Soper DE. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases, 52(5), e103–e120.
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE. 2010. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clinical Infectious Diseases, 50(5), 625–663.
Hsia, CY, Yang HY, Chang CH, Lin HL, Wu CY, Hsiao MC, Hung PH, Liu SH, Weng CH, Lee CC, Yen TH, Chen YC, Wu TC. 2015. Risk factors for development of septic shock in patients with urinary tract infection. BioMed Research International, 2015, 717094.
IAUI, I. A. U. I. 2020. Panduan Tatalaksana Infeksi Saluran Kemih dan Genitalia Pria 2021.
Johnson JR, Russo TA. 2018. Acute pyelonephritis in adults. New England Journal of Medicine, 378(1), 48–59.
Kallen AJ, Welch HG, Sirovich BE. 2006. Current antibiotic therapy for isolated urinary tract infections in women. Archives of Internal Medicine, 166(6), 635.
Permenkes No. 28 Tahun 2021 Pedoman Penggunaan Antibiotik.
Krause PJ, Auwaerter PG, Bannuru RR, Branda JA, Falck-Ytter YT, Lanto, PM, Lavergne V, Meissner HC, Osani MC, Rips JG, Sood SK, Vannier E, Vaysbrot EE, Wormser GP. 2021. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on diagnosis and management of babesiosis. Clinical Infectious Diseases, 72(2), e49–e64.
Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Spielman A. 2008. Persistent and relapsing babesiosis in immunocompromised patients. Clinical Infectious Diseases, 46(3), 370–376.
Kumar A, Zarychanski R, Light B, Parrillo J, Maki D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., Martinka, G., Keenan, S., Wood, G., Arabi, Y., Feinstein, D., Kumar, A., Dodek, P., Kravetsky, L., & Doucette, S. (2010). Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis. Critical Care Medicine, 38(9), 1773–1785.
Lantos PM, Rumbaugh J, Bockenstedt LK, Falck‐Ytter YT, Aguero‐Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Cody Meissner H, Nigrovic LE, Zemel LS. 2021. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the prevention, diagnosis, and treatment of lyme disease. Arthritis Care & Research, 73(1), 1–9.
Leekha S, Terrell CL, Edson RS. 2011. General principles of antimicrobial therapy. Mayo Clinic Proceedings, 86(2), 156–167.
Leem GC, Burgess DS. 2020. Antimicrobial Regimen selection. In J. T. DiPiro (Ed.), Pharmacotherapy a Pathophysiologic Approach Handbook (Eleventh, pp. 1771–1784). McGraw Hill.
Leibovici-Weissman Y, Neuberger A, Bitterman R, Sinclair D, Salam M A, Paul M. 2014. Antimicrobial drugs for treating cholera. Cochrane Database of Systematic Reviews, 2014(6).
Lexicomp. 2024. LevoFLOXacin Systemic (Lexi-Drugs Multinational) - UpToDate® LexidrugTM. Lexicomp.
Lexicomp. 2010. Sulbactam (Martindale: The Complete Drug Reference). Lexicomp.
Lexicomp. 2024a. Ciprofloxacinin Systemic (Lexi-Drugs Multinational); Pharmacokinetics. Lexicomp.
Lexicomp. 2024b. Meropenem (Lexi-Drugs Multinational); Adverse Reactions 1% to 10%. Lexicomp.
Lexicomp. 2024c. Adverse Reactions: LevoFLOXacin.
Lexicomp. 2024d. CefTRIAXone (Lexi-Drugs Multinational). Lexicomp.
Lexicomp. 2024e. Gentamicin (Systemic); Adverse Reactions. Lexicomp.
Lexicomp. 2024f. Gentamicin (Systemic); Dosing: Altered Kidney Function: Adult. Lexicomp.
Lexicomp. 2024g. Gentamycin systemic; Pharmacokinetics. Lexicomp.
M File T. 2023. Treatment of community-acquired pneumonia in adults who require hospitalization. UpToDate.
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. 2019. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45–e67.
Minardi D, d’Anzeo G, Cantoro D, Conti A, Muzzonigro G. 2011. Urinary tract infections in women: Etiology and treatment options. International Journal of General Medicine, 4, 333–343.
Moustafa F, Nguyen G, Mathevon T, Baud O, Saint-Denis J, Dublanchet N, Pereira B, Shinjo C, Romaszko JP, Dopeux L, Dutheil F, Schmidt J. 2016. Evaluation of the efficacy and tolerance of a short 7 day third-generation cephalosporin treatment in the management of acute pyelonephritis in young women in the emergency department. Journal of Antimicrobial Chemotherapy, 71(6), 1660–1664.
Mueller B, Roberts J, Heung M. 2024. Dosing levoFloxacin: Altered Kidney Function: Adult; The renal dosing recommendations are based upon the best available evidence and clinical expertise.
Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. 2009. Immunoactive prophylaxis of recurrent urinary tract infections: A meta-analysis. International Journal of Antimicrobial Agents, 33(2), 111–119.
Najar MS, Saldanha CL, Banday KA. 2009. Approach to urinary tract infections. Indian Journal of Nephrology, 19(4), 129–139.
Nawakasari N, Nugraheni AY. 2019. Evaluasi penggunaan antibiotik pada pasien infeksi saluran kemih di instalasi rawat inap RSUP X di Klaten tahun 2017. Pharmacon: Jurnal Farmasi Indonesia, 16(1), 38–48.
NICE. 2018. Pyelonephritis (acute): Antimicrobial prescribing guideline, evidence review. National Institute for Health and Care Excellence, 1–100.
Nicolle LE. 2008. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urologic Clinics of North America, 35(1), 1–12.
Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, Eckert LO, Geerlings SE, Köves B, Hooton TM, Juthani-Mehta M, Knight SL, Saint S, Schaeffer AJ, Trautner B, Wullt B, Siemieniuk R. 2019. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases.
Paul R. 2018. State of the globe: Rising antimicrobial resistance of pathogens in urinary tract infection. Journal of Global Infectious Diseases, 10(3), 117–118.
Pichichero ME. 2024). Treatment and prevention of streptococcal pharyngitis in adults and children. UpToDate.
Powell AM, Nyirjesy P. (2022). Acute cervicitis. UpToDate.
Ratliff A, Oliphant C. 2022. Patient Assessment, Antimicrobial Selection, and Stewardship. In M. A. Chisholm-Burns, T. L. Schwinghammer, P. M. Malone, J. M. Kolesar, K. C. Lee, & P. Brandon Bookstaver (Eds.), Pharmacotherapy Principles and Practice (Sixth, pp. 1151–1166). McGraw Hill, LLC.
Regamey C, Gordon RC, & Kirby WMM. 1973. Comparative pharmacokinetics of tobramycin and gentamicin. Clinical Pharmacology & Therapeutics, 14(3), 396–403.
Riddle MS, DuPont HL, Connor BA. 2016. ACG clinical guideline: Diagnosis, treatment, and prevention of acute diarrheal infections in adults. American Journal of Gastroenterology, 111(5), 602–622.
Rubenstein JN, Schaeffer AJ. 2003. Managing complicated urinary tract infections. Infectious Disease Clinics of North America, 17(2), 333–351.
Ryanto S, Wong M, Czarniak P, Parsons R, Travers K, Skinner M, Sunderland B. 2019. The use of initial dosing of gentamicin in the management of pyelonephritis/urosepsis: A retrospective study. PLOS ONE, 14(1), e0211094.
Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell III PW, for the Macrolide Study Group. 2003. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. JAMA, 290(13), 1749. https://doi.org/10.1001/jama.290.13.1749
Sanchez E, Vannier E, Wormser GP, Hu LT. 2016. Diagnosis, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis. JAMA, 315(16), 1767.
Sanchez M. 2002. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emergency Medicine Journal, 19(1), 19–22.
Sandberg T, Skoog G, Hermansson AB, Kahlmeter G, Kuylenstierna N, Lannergård A, Otto G, Settergren B, Ekman GS. 2012. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: A randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. The Lancet, 380(9840), 484–490.
Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ. 2015. Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathogens, 11(1), e1004599.
Shankar M, Narasimhappa S, Madhura NS. 2021. Urinary Tract infection in chronic kidney disease population: A clinical observational study. Cureus, 13(1), e12486.
Shih G, Wallace R. 2024. First-trimester pregnancy termination: Uterine aspiration. Uptodate.
Smith D, Du Rand I, Addy CL, Collyns T, Hart SP, Mitchelmore PJ., Rahman NM, Saggu R. 2020. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease. Thorax, 75(5), 370–404.
Spach DH. 2022. Bartonella infections in people with HIV. UpToDate.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. 2014. Executive summary on Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 59(2), 147–159.
Swanson RN, Lainez-Ventosilla A, De Salvo MC, Dunne MW, Amsden GW. 2005. Once-daily Azithromycin for 3 days compared with Clarithromycin for 10 days for acute exacerbation of chronic bronchitis. Treatments in Respiratory Medicine, 4(1), 31–39.
Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. 2023. Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant G-negative infections. Clinical Infectious Diseases.
Trimayanti Y, Nuryastuti T, Yuniarti N. 2021. Evaluasi kesesuaian antibiotik empiris terhadap clinical outcome pada pasien infeksi saluran kemih (ISK) di RSUD Sijunjung, Sumatera Barat. Majalah Farmaseutik, 18(3), 315–323.
Udupa V, Prakash V. 2019. Gentamicin-induced acute renal damage and its evaluation using urinary biomarkers in rats. Toxicology Reports, 6, 91–99.
Ventola CL. 2015. The antibiotic resistance crisis: part 1: Causes and threats. P & T : A Peer-Reviewed Journal for Formulary Management, 40(4), 277–283.
Warzecha D, Pietrzak B, Urban A, Wielgoś M. 2021. How to avoid drug resistance during treatment and prevention of urinary tract infections. Menopausal Review, 20(4), 217–221.
Wells WG. 2004. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. Journal of Antimicrobial Chemotherapy, 53(suppl2), ii67–ii74.
WHO. 2005. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. World Health Organization.
Wie SH, Kim HW, Chang UI. 2014. Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women. Clinical Microbiology and Infection, 20(11), 1211–1218.
Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T. 2012. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): A randomised, double-blind, placebo-controlled trial. The Lancet, 380(9842), 660–667.
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. 2021. Sexually transmitted infections treatment guidelines, 2021. MMWR. Recommendations and Reports, 70(4), 1–187.
Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, Neuberger A, Ghanem-Zoubi N, Santoro A, Eliakim-Raz N, Pertzov B, Steinmetz T, Stern A, Dickstein Y, Maroun E, Zayyad H, Bishara J, Alon D, Edel Y, Pau, M. 2019. Seven versus 14 days of antibiotic therapy for uncomplicated G-negative bacteremia: A noninferiority randomized controlled trial. Clinical Infectious Diseases, 69(7), 1091–1098.
Yusnita R, Meylina L, Ibrahim A, Rijal L. 2017. Kajian efektifitas penggunaa antibiotik pada pasien infeksi saluran kemih (ISK) Di Rumah Sakit Samarinda Medika Citra (SMC) Kota Samarinda. Proceeding of the 5th Mulawarman Pharmaceuticals Conferences, 205–222.
Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, Bowe WP, Graber EM, Harper JC, Kang S, Keri JE, Leyden JJ, Reynolds RV, Silverberg NB, Stein Gold LF, Tollefson MM, Weiss JS, Dolan NC, Sagan AA, Bhushan R. 2016. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 74(5), 945-973.e33.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
